Analysts’ Weekly Ratings Updates for Aflac (AFL)

A number of firms have modified their ratings and price targets on shares of Aflac (NYSE: AFL) recently:

• 5/26/2026 – Aflac had its “overweight” rating reaffirmed by Piper Sandler. They now have a $130.00 price target on the stock, up from $125.00.
• 5/21/2026 – Aflac had its price target raised by Morgan Stanley from $120.00 to $125.00. They now have an “equal weight” rating on the stock.
• 5/15/2026 – Aflac was upgraded by Weiss Ratings from “buy (b-)” to “buy (a-)”.
• 5/9/2026 – Aflac was upgraded by Wall Street Zen from “sell” to “hold”.
• 5/5/2026 – Aflac had its price target lowered by Wells Fargo & Company from $116.00 to $111.00. They now have an “equal weight” rating on the stock.
• 5/4/2026 – Aflac was given a new $104.00 price target by Mizuho.
• 5/1/2026 – Aflac was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.
• 5/1/2026 – Aflac had its price target lowered by Piper Sandler from $130.00 to $125.00. They now have an “overweight” rating on the stock.
• 4/30/2026 – Aflac was given a new $99.00 price target by Barclays PLC. They now have an “underweight” rating on the stock.
• 4/13/2026 – Aflac was given a new $102.00 price target by Mizuho. They now have an “underperform” rating on the stock.
• 4/10/2026 – Aflac had its price target raised by Keefe, Bruyette & Woods from $113.00 to $115.00. They now have a “market perform” rating on the stock.
• 4/10/2026 – Aflac had its price target lowered by Wells Fargo & Company from $118.00 to $116.00. They now have an “equal weight” rating on the stock.
• 4/9/2026 – Aflac was upgraded by Evercore Inc from “strong sell” to “strong-buy”.
• 4/9/2026 – Aflac had its price target lowered by UBS Group AG from $116.00 to $114.00. They now have a “neutral” rating on the stock.
• 4/2/2026 – Aflac was upgraded by Piper Sandler to “strong-buy”.

Aflac Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Wednesday, May 20th will be given a dividend of $0.61 per share. The ex-dividend date of this dividend is Wednesday, May 20th. This represents a $2.44 dividend on an annualized basis and a yield of 2.1%. Aflac’s payout ratio is 27.70%.

Insider Buying and Selling at Aflac

In other Aflac news, Director Arthur Reginald Collins sold 2,300 shares of Aflac stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $116.55, for a total transaction of $268,065.00. Following the completion of the sale, the director directly owned 6,186 shares of the company’s stock, valued at $720,978.30. The trade was a 27.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Thomas J. Kenny sold 1,740 shares of Aflac stock in a transaction on Friday, May 15th. The shares were sold at an average price of $116.57, for a total value of $202,831.80. Following the sale, the director directly owned 13,219 shares of the company’s stock, valued at approximately $1,540,938.83. This trade represents a 11.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 814,028 shares of company stock valued at $91,815,931 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.